These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11296046)

  • 21. Contemporary management of spasmodic dysphonia.
    Sulica L
    Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):543-8. PubMed ID: 15548915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of using botulism toxin in the treatment of spasmodic dysphonia].
    Larrosa F; Idígora A; Aguilar F; Riera L; Martí MJ; Valls J
    Acta Otorrinolaringol Esp; 2002 Jan; 53(1):27-31. PubMed ID: 11998515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia.
    Damrose JF; Goldman SN; Groessl EJ; Orloff LA
    J Voice; 2004 Sep; 18(3):415-22. PubMed ID: 15331116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes.
    Mehta RP; Goldman SN; Orloff LA
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):393-9. PubMed ID: 11296047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
    Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of oromandibular dystonia with botulinum A toxin: a series of cases.
    Teemul TA; Patel R; Kanatas A; Carter LM
    Br J Oral Maxillofac Surg; 2016 Dec; 54(10):1080-1084. PubMed ID: 27776922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
    Whitaker J; Butler A; Semlyen JK; Barnes MP
    Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
    Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
    Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
    Ford B; Louis ED; Greene P; Fahn S
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):472-8. PubMed ID: 9771768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Spasmodic dysphonia in course of Meige's syndrome--case report].
    Zalesska-Krecicka M; Morawska-Kochman M; Wierzbicka E; Skrzypek A; Krecicki T
    Otolaryngol Pol; 2006; 60(5):779-81. PubMed ID: 17263254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe tongue protrusion dystonia: clinical syndromes and possible treatment.
    Schneider SA; Aggarwal A; Bhatt M; Dupont E; Tisch S; Limousin P; Lee P; Quinn N; Bhatia KP
    Neurology; 2006 Sep; 67(6):940-3. PubMed ID: 17000958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
    Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
    J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients.
    Lo SE; Rosengart AJ; Novakovic RL; Kang UJ; Shah DN; Khan MA; Dalvi A; Goldenberg FD; Macdonald RL; Frank JI
    Neurocrit Care; 2005; 3(2):139-45. PubMed ID: 16174883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia.
    Adams SG; Durkin LC; Irish JC; Wong DL; Hunt EJ
    Laryngoscope; 1996 Mar; 106(3 Pt 1):296-300. PubMed ID: 8614192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
    Blitzer A; Brin MF; Stewart CF
    Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient benefit from treatment with botulinum neurotoxin A for functional indications in otorhinolaryngology.
    Braun T; Gürkov R; Hempel JM; Berghaus A; Krause E
    Eur Arch Otorhinolaryngol; 2010 Dec; 267(12):1963-7. PubMed ID: 20563590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.